Login / Signup

In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin-layer (PRF)-a laboratory evaluation of a modern, autologous wound treatment.

Daniela GergesFlorian ThalhammerMatthias Gerhard Vossen
Published in: PloS one (2017)
Our Results show that a weekly dressing regimen may be justified in wounds treated with PRF plus amikacin or teicoplanin, since bacteria will be eradicated over a considerable period of time after a single application of PRF.
Keyphrases
  • wound healing
  • platelet rich plasma
  • bone marrow
  • cell therapy
  • combination therapy